RxDoctor Payments Data

Kelly Holt

Adult Health · San Diego, CANPI 1205169711

Payments from drug & device makers

$326in general payments, 2019–2025

Across 14 payments — averaging $23.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$166
  • Novo Nordisk$42
  • Pharmacyclics LLC, An Abbvie Company$33
  • Lilly USA, LLC$26
  • Boehringer Ingelheim$24
  • Boston Scientific$21
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$326100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$326 in reported general payments places this provider in the 45th percentile of 785 adult health providers in California.

See all adult health providers in California

Medicare billing

Part B allowed, 2024
$103,181
Medicare patients
482
Services billed
1,040

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban61$65,550
OzempicSemaglutide64$65,026
ProliaDenosumab33$55,687
MounjaroTirzepatide23$32,212
XareltoRivaroxaban15$22,568
JardianceEmpagliflozin15$21,090
MyrbetriqMirabegron17$20,436
Repatha SureclickEvolocumab14$7,552
PremarinEstrogens, Conjugated19$4,106
Estradiol59$4,011
SynthroidLevothyroxine Sodium48$3,311
Levothyroxine Sodium213$2,584
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,580
Atorvastatin Calcium236$2,495
Valsartan61$2,229

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$15$69,65780 claims
Novo NordiskOzempic$42$65,02664 claims
Lilly USA, LLCMounjaro$26$32,21223 claims
Boehringer IngelheimJardiance$24$21,09015 claims
AbbVieSynthroid$166$3,31148 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 785 adult health providers in California.

Other adult health in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →